about
Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.Optimizing donor selection in a cord blood bank.Excluding Anti-cytomegalovirus Immunoglobulin M-Positive Cord Blood Units Has a Minimal Impact on the Korean Public Cord Blood Bank Inventory.The density of CD10 corresponds to commitment and progression in the human B lymphoid lineage.Stromal cell-free conditions favorable for human B lymphopoiesis in culture.Reconstruction of hematopoietic inductive microenvironment after transplantation of VCAM-1-modified human umbilical cord blood stromal cells.Titrating graft-versus-host disease: is it worth a try?Mean platelet volume reflect hematopoietic potency and correlated blood group o in cord blood from healthy newbornDonor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation.Prophylaxis of acute GVHD: manipulate the graft or the environment?Quality of cord blood cryopreserved for up to 5 years.Multicenter study to evaluate a new enumeration method for hematopoietic stem cell collection management.Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma.Increased numbers of total nucleated and CD34+ cells in blood group O cord blood: an analysis of neonatal innate factors in the Korean population.
P2860
Q30997153-F644D5A8-788C-460C-9FB7-819F4B3595D4Q33448051-B75E669A-5032-45E7-8758-2017F94CE373Q33458521-A55EB379-3154-4471-95AB-08D5AB62106BQ33707714-3BF56E42-4197-454A-B002-527771490C9CQ33989141-DEF42765-9CE1-4E95-8DD9-C6C3F3BEF4A8Q34181911-8A7E510B-9C49-42F0-A616-C8C72E2E9CB8Q36605959-97CEB106-A59E-4CD1-AEA8-E833C2DAE220Q36763354-E7636FF1-3F9E-4B2C-9D72-BBAB1F5023EEQ37008223-CC66AA40-E598-4466-93D3-A10A8FDE1A25Q37173456-F0FC502B-394C-4E2B-98E7-00114F11FBF2Q37683269-64FB5CB7-B078-4F3F-B611-BAFD02737D73Q38707678-0743C519-05C8-4476-AC22-B94904E0D38CQ47318504-C7416BD8-F1F5-4C5D-B802-C2B7375E09BBQ53413632-F1C48E1E-8BC7-45EF-8695-3B25BC86CFDB
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Optimizing engraftment--source and dose of stem cells.
@ast
Optimizing engraftment--source and dose of stem cells.
@en
Optimizing engraftment--source and dose of stem cells.
@nl
type
label
Optimizing engraftment--source and dose of stem cells.
@ast
Optimizing engraftment--source and dose of stem cells.
@en
Optimizing engraftment--source and dose of stem cells.
@nl
prefLabel
Optimizing engraftment--source and dose of stem cells.
@ast
Optimizing engraftment--source and dose of stem cells.
@en
Optimizing engraftment--source and dose of stem cells.
@nl
P356
P1476
Optimizing engraftment--source and dose of stem cells.
@en
P2093
John Barrett
Norbert Schmitz
P356
10.1053/SHEM.2002.29245
P577
2002-01-01T00:00:00Z